AIIMS Delhi to start screening children for Covaxin trials: Report
After the recruitment of 6 to 12 yr old children AIIMS Delhi will be conducting trials for the age group 2 to 6 yr old. The trails are taking place at 525 centres.
New Delhi: The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday.According to sources, the recruitment for clinical trials of Covaxin among those aged 12 to 18 years is over. They have been given a single dose of vaccine. Also Read:AIIMS Delhi to start paediatric trials...
New Delhi: The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday.
According to sources, the recruitment for clinical trials of Covaxin among those aged 12 to 18 years is over. They have been given a single dose of vaccine.
Also Read:AIIMS Delhi to start paediatric trials for Covaxin: Report
After the recruitment of 6-12 yr old children AIIMS Delhi will be conducting trials for the age group 2-6 yr old. The trails are taking place at 525 centres.
AIIMS Patna, Mysore Medical College and Reaserch Institute in Karnataka have also been selected to conduct clinical trials on children.
"We have started recruitment for children aged 6-12 years. Recruitments for clinical trails on children aged 12-18 years is over. They will be kept under observation." said Prabhat Kumar Singh, Director, AIIMS, Patna.
Also Read: Covaxin trials: AIIMS Delhi starts screening of children
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd